HEPASAFE
LIVE

Serial Number

79144432

Owner

PHARMA ACTION GmbH

Attorney

SARA M. DORCHAK

Filing Date

Dec 18, 2013

Add to watchlist:

No watchlists yet
View on USPTO

HEPASAFE Trademark

Serial Number: 79144432 • Registration: 4634923

HEPASAFE is a trademark filed by PHARMA ACTION GmbH on December 18, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

PHARMA ACTION GmbH (3 trademarks)

Kurfürstendamm 133

Entity Type: 99

BIOIBERICA GmbH (3 trademarks)

Werner Strasse 95

Entity Type: 99

Trademark Details

Filing Date

December 18, 2013

Registration Date

November 11, 2014

Published for Opposition

August 26, 2014

Cancellation Date

December 18, 2023

Goods & Services

Pharmaceutical preparations used for the treatment of deep vein thrombosis, pulmonary embolism, arterial embolism, unstable angina pectoris, and cystic fibrosis; Veterinary preparations used for the treatment of deep vein thrombosis, pulmonary embolism, arterial embolism, and unstable angina pectoris in respect to cats, dogs, rabbits, domestic rodents, horses, cows, pigs, sheeps, and goats; Adhesive medical plasters; Medical dressings; Bandages for dressings; Biological preparations for medical use in the treatment of deep vein thrombosis, pulmonary embolism, arterial embolism, unstable angina pectoris, and cystic fibrosis; Biological preparations for veterinary purposes in the treatment of deep vein thrombosis, pulmonary embolism, arterial embolism, and unstable angina pectoris in respect to cats, dogs, rabbits, domestic rodents, horses, cows, pigs, sheeps, and goats; Chemical preparations for pharmaceutical or medical use in the treatment of deep vein thrombosis, pulmonary embolism, arterial embolism, unstable angina pectoris, and cystic fibrosis; Chemical preparations for veterinary purposes in the treatment of deep vein thrombosis, pulmonary embolism, arterial embolism, and unstable angina pectoris in respect to cats, dogs, rabbits, domestic rodents, horses, cows, pigs, sheeps, and goats; Blood for medical purposes; Anticoagulants for blood; Blood plasma; Blood purification preparations; Ointments for pharmaceutical purposes in the treatment of superficial thrombophlebitis, superficial bruising, haematoma, haemorrhoids, perianal eczema, pruritus, anal fissure, proctitis, periproctitis; Medical preparations for prophylaxis and therapy of thrombosis

Medical and veterinary services; Pharmacy advice, namely, pharmaceutical advice, in particular providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Scientific laboratory services in the field of blood and blood disorders; Scientific research in the field of blood and blood disorders; Medical research; Research in the field of pharmacy and/or medicine; Research in the field of chemistry; Performance of chemical analyses; Biological research; Quality control for others; Performance of clinical drug testing, namely, conducting clinical drug trials for others

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 13, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jul 13, 2024 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jul 17, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
May 23, 2022 INTS
INVALIDATION PROCESSED
May 23, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 28, 2022 INTR
CANCELLED SECTION 71
May 28, 2021 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 11, 2019 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 22, 2018 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Mar 1, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 2, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 10, 2015 FICS
FINAL DISPOSITION PROCESSED
Apr 10, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 11, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2014 NPUB
PUBLISHED FOR OPPOSITION
Aug 26, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Aug 22, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 6, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 6, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 6, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 24, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 23, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 23, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 23, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 23, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2014 CRFA
ASSIGNED TO LIE
Jul 4, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 27, 2014 TROA
REFUSAL PROCESSED BY IB
Apr 18, 2014 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 1, 2014 RFCS
REFUSAL PROCESSED BY MPU
Apr 1, 2014 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 1, 2014 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 29, 2014 RFCR
NON-FINAL ACTION WRITTEN
Mar 28, 2014 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 28, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 27, 2014 REPR